Lannett Company, Inc. (LCINQ)

OTCMKTS: LCINQ · Delayed Price · USD
-0.0003 (-1.30%)
Jun 7, 2023 4:00 PM EDT - Market closed
Market Cap 273.25K
Revenue (ttm) 310.67M
Net Income (ttm) -259.09M
Shares Out 10.31M
EPS (ttm) -25.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,284
Open 0.0265
Previous Close 0.0268
Day's Range 0.0265 - 0.0275
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a


Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular,... [Read more]

Sector Healthcare
Founded 1942
Employees 564
Stock Exchange OTCMKTS
Ticker Symbol LCINQ
Full Company Profile

Financial Performance

In 2022, LCINQ's revenue was $340.58 million, a decrease of -28.86% compared to the previous year's $478.78 million. Losses were -$231.62 million, -36.28% less than in 2021.

Financial Statements


There is no news available yet.